JS

Jim Sullivan

Chief Executive Officer at Vanqua Bio

Greater Chicago Area

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $1,000,000.00

  • Max Investment:

    $75,000,000.00

  • Target Investment:

    $4,000,000.00

Skills

Pharmaceutical Industry
Life Sciences
Biotechnology
Clinical Development
Drug Discovery
Clinical Trials
Biopharmaceuticals
Oncology
Immunology
Regulatory Affairs
Neuroscience
Biologics
Chemistry
Molecular Pharmacology

Education

Lists including Jim

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

VB
Vanqua Bio

2019

  • Chief Executive Officer

    2019

O
OrbiMed

2019

  • Venture Partner

    2019

NU
Northwestern University

2009

  • Adjunct Professor, Department of Pharmacology

    2009

A
AbbVie

2013 - 2018

  • Vice President Global Discovery

    2013 - 2018

A
Abbott

1995 - 2012

  • Vice President Global Pharmaceutical Discovery

    2008 - 2012

  • Vice President, Neuroscience Discovery

    2001 - 2008

  • Director Neuroscience Discovery

    1997 - 2000

  • Project Leader

    1995 - 1997

A
Abbott

1991 - 1993

  • Sr Research Scientist, Neuroscience Discovery

    1991 - 1993

NP
Nova Pharmaceuticals

1990 - 1991

  • Research Scientist

    1990 - 1991

NU
Northwestern University

1987 - 1990

  • Postdoctoral Fellow, Department of Neurobiology

    1987 - 1990